P. Hedera

发表

2D and 3D high resolution gradient echo functional imaging of the brain: Venous contributions to signal in motor cortex studies

Jean A. Tkach, J. Lewin, E. Haacke, 1994, NMR in biomedicine.

Cortical localization of human sustained attention: detection with functional MR using a visual vigilance paradigm.

J. Lewin, J. Duerk, L. Friedman, 1996, Journal of computer assisted tomography.

Cortical asymmetry in Parkinson's disease: early susceptibility of the left hemisphere

B. Dawant, D. Zald, B. Landman, 2016, Brain and behavior.

Emerging strategies in the management of essential tremor.

P. Hedera, 2017 .

Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical Trial

Jamie L. Adams, L. Seeberger, H. D. Rosas, 2020, Journal of clinical medicine.

Assessment of cerebral blood flow reserve using functional magnetic resonance imaging

J S Lewin, E M Haacke, S Lai, 1996, Journal of magnetic resonance imaging : JMRI.

Identification of vascular structures as a major source of signal contrast in high resolution 2D and 3D functional activation imaging of the motor cortex at l.5T preliminary results

E. Haacke, L. Friedman, S. Lai, 1993, Magnetic resonance in medicine.

UPDATE ON THE GENETICS OF MOVEMENT DISORDERS

P. Hedera, F. Phibbs, Fenna Phibbs, 2010, Continuum.

Effect of collateral flow patterns on outcome of carotid occlusion.

P. Hedera, P. Traubner, J. Bujdáková, 1995, European neurology.

Methods for Surgical Targeting of the STN in Early-Stage Parkinson’s Disease

C. Camalier, P. Konrad, C. Kao, 2013, Front. Neurol..

Mutations in GABRA1, GABRA5, GABRG2 and GABRD receptor genes are not a major factor in the pathogenesis of familial focal epilepsy preceded by febrile seizures

J. Sutcliffe, J. Haines, P. Hedera, 2006, Neuroscience Letters.

Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy

P. Hedera, B. Abou-Khalil, M. Blair, 2006, Epilepsy Research.

The Optimal Pallidal Target in Deep Brain Stimulation for Dystonia: A Study Using a Functional Atlas Based on Nonlinear Image Registration

Pierre-François D'Haese, Benoit M Dawant, Chen Li, 2014, Stereotactic and Functional Neurosurgery.

Influence of extreme head rotations on brainstem auditory evoked potentials (BAEP)

P. Hedera, 1995, Clinical Neurology and Neurosurgery.

Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease

David M. Shade, M. Delong, J. Ostrem, 2018, Neurology.

Essential tremor impairs the ability to suppress involuntary action impulses

W. P. van den Wildenberg, P. Hedera, F. Phibbs, 2022, Experimental Brain Research.

Stroke risk factors and development of collateral flow in carotid occlusive disease

P. Hedera, P. Traubner, J. Bujdáková, 1998, Acta neurologica Scandinavica.

Hereditary Myelopathies

P. Hedera, 2018, Continuum.

Strumpellin and Spartin, Hereditary Spastic Paraplegia Proteins, are Binding Partners

P. Hedera, Jiali Zhao, 2015, Journal of experimental neuroscience.

The effect of HSP-causing mutations in SPG3A and NIPA1 on the assembly, trafficking, and interaction between atlastin-1 and NIPA1

Emmanuel J. Botzolakis, R. Macdonald, P. Hedera, 2011, Molecular and Cellular Neuroscience.

Whole‐exome sequencing for variant discovery in blepharospasm

R. Uitti, Z. Wszolek, G. Defazio, 2018, Molecular genetics & genomic medicine.

Left-sided embryonic expression of the BCL-6 corepressor, BCOR, is required for vertebrate laterality determination.

L. Biesecker, A. Nordgren, J. Johnston, 2007, Human molecular genetics.

Novel THAP1 sequence variants in primary dystonia

A. Blitzer, D. Tarsy, R. Uitti, 2010, Neurology.

PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper

P. Hedera, C. Hong, K. Ess, 2015, Neurobiology of Disease.

Paroxysmal dystonic choreoathetosis: tight linkage to chromosome 2q.

M. Leppert, R. Albin, P. Hedera, 1996, American journal of human genetics.

Autosomal recessive primary generalized dystonia in two siblings from a consanguineous family

P. Hedera, P. Moretti, J. Fink, 2005, Movement disorders : official journal of the Movement Disorder Society.

Paroxysmal dystonic choreoathetosis linked to chromosome 2q: Clinical analysis and proposed pathophysiology

R. Albin, P. Hedera, J. Fink, 1997, Neurology.

Speech-activated Myoclonus Mimicking Stuttering in a Patient with Myoclonus–Dystonia Syndrome

P. Hedera, David Isaacs, 2016, Tremor and other hyperkinetic movements.

Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study

V. P. Misra, R. Jech, S. Ochudło, 2019, Journal of Neurology.

How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study

V. P. Misra, R. Jech, S. Ochudło, 2019, Journal of Neurology.

INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin

V. P. Misra, R. Jech, S. Ochudło, 2017, Journal of Neurology.

Hereditary spastic paraplegia or spinocerebellar ataxia? Not always as easy as it seems

P. Hedera, 2009, European journal of neurology.

Genomic, transcriptomic, and metabolomic profiles of hiPSC-derived dopamine neurons from clinically discordant brothers with identical PRKN deletions

D. Dykxhoorn, P. Hedera, A. Griswold, 2022, npj Parkinson's Disease.

Liver transplant for neurologic Wilson disease

P. Hedera, O. Bandmann, K. Weiss, 2020, Neurology.

Wilson's disease: A master of disguise.

P. Hedera, 2019, Parkinsonism & related disorders.

The Application of Clinical Genetics Dovepress Update on the Clinical Management of Wilson's Disease

P. Hedera, 2022 .

Can lifestyle modification slow progression of Parkinson disease?

P. Hedera, T. Davis, 2017, Neurology.

Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin II. The denture cream is a primary source of excessive zinc.

P. Hedera, A. Peltier, J. Fink, 2009, Neurotoxicology.

Novel PRRT2 mutation in an African-American family with paroxysmal kinesigenic dyskinesia

P. Hedera, M. LeDoux, D. Momčilović, 2012, BMC Neurology.

Skewed X‐inactivation in carriers establishes linkage in an X‐linked deafness–mental retardation syndrome

Donna M. Martin, J. Douglas, D. M. Martin, 2004 .

Mitochondrial analysis in autosomal dominant hereditary spastic paraplegia

S. Dimauro, P. Hedera, J. Fink, 2000, Neurology.

Prolonged Coma after Continuous Sedation with Propofol

P. Hedera, B. Flöer, J. Wald, 1999, European Neurology.

Two patients with monomelic ulnar duplication with mirror hand polydactyly: Segmental Laurin–Sandrow syndrome

P. Hedera, J. Innis, 2004, American journal of medical genetics. Part A.

A new locus for autosomal dominant generalized epilepsy associated with mild mental retardation on chromosome 3p

J. Haines, P. Hedera, B. Abou-Khalil, 2011, Epilepsia.

Complicated autosomal recessive hereditary spastic paraplegia

P. Hedera, O. Bandmann, 2008, Neurology.

REEPing the benefits of an animal model of hereditary spastic paraplegia.

A. Deutch, R. Colbran, P. Hedera, 2013, The Journal of clinical investigation.

NOTCHing toward better understanding of CADASIL

P. Hedera, 2020, Neurology.

Evaluation of SCN8A as a candidate gene for autosomal dominant essential tremor.

M. Meisler, P. Hedera, L. Sharkey, 2009, Parkinsonism & related disorders.

Familial genetic predisposition, epilepsy localization and antecedent febrile seizures

P. Hedera, B. Abou-Khalil, J. Haines, 2007, Epilepsy Research.

Apolipoprotein E-E4 Alleles in Cerebral Amyloid Angiopathy and Cerebrovascular Pathology Associated with Alzheimer's Disease

D. Premkumar, P. Hedera, R. Friedland, 2007 .

Hereditary spastic paraplegia linked to chromosome 14q11-q21: reduction of the SPG3 locus interval from 5.3 to 2.7 cM

P. Hedera, K. Kleopa, J. Fink, 2001, Journal of medical genetics.

Mutation in KIF5A can also cause adult-onset hereditary spastic paraplegia

P. Hedera, M. Blair, Shaochun Ma, 2006, Neurogenetics.

Novel mutation in the SPG3A gene in an African American family with an early onset of hereditary spastic paraplegia.

J. Haines, G. Fenichel, P. Hedera, 2004, Archives of neurology.

Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.

P. Hedera, P. Moretti, F. Askari, 2006, Archives of neurology.

Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy.

P. Hedera, F. Askari, J. Fink, 2003, Archives of neurology.

Treatment of Wilson's disease with zinc. XVII: Treatment during pregnancy

P. Hedera, J. Fink, G. Brewer, 2000, Hepatology.

Prenatal diagnosis of hereditary spastic paraplegia

P. Hedera, J. Fink, T. Tukel, 2001, Prenatal diagnosis.

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: Study of two American families with predominant dementia

P. Hedera, R. Friedland, 1997, Journal of the Neurological Sciences.

Confined Thalamic Deep Brain Stimulation in Refractory Essential Tremor

P. Konrad, P. Hedera, F. Phibbs, 2018, Stereotactic and Functional Neurosurgery.

Laing early onset distal myopathy: slow myosin defect with variable abnormalities on muscle biopsy

F. Mastaglia, P. Hedera, N. Laing, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Amyloid-β Protein Angiopathies Masquerading as Alzheimer's Disease?a

D. Premkumar, P. Hedera, R. Friedland, 1997 .

Adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia: report of five cases and a new mutation

P. Hedera, B. Mobley, S. Pawate, 2013, Journal of Neurology.

Apolipoprotein E-E4Alleles inCerebral Amyloid Angiopathy andCerebrovascular Pathology Associated withAlzheimer's Disease

P. Hedera, 1996 .

(3-amyloid vasoactivity in Alzheimer's disease

D. Gurwitz, P. Hedera, R. Kalaria, 1996, The Lancet.

Duane's syndrome with giant aneurysm of the vertebral basilar arterial junction.

P. Hedera, R. Friedland, 1993, Journal of clinical neuro-ophthalmology.

Compressions of Carotid and Vertebral Arteries in Assessment of Intracranial Collateral Flow: Correlation Between Angiography and Transcranial Doppler Ultrasonography

P. Hedera, P. Traubner, J. Bujdáková, 1994, Angiology.

New ideas in epilepsy genetics: novel epilepsy genes, copy number alterations, and gene regulation.

P. Hedera, C. Gurnett, 2007, Archives of neurology.

Blood flow velocities in basilar artery during rotation of the head

P. Hedera, P. Traubner, J. Bujdáková, 1993, Acta neurologica Scandinavica.

Myelopolyneuropathy Due to Copper Deficiency or Zinc Excess?—Reply

P. Hedera, G. Brewer, 2004 .

Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin: further support for existence of a new zinc overload syndrome.

P. Hedera, J. Fink, P. Bockenstedt, 2003, Archives of neurology.

Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1).

F. Mastaglia, P. Hedera, N. Laing, 2004, American journal of human genetics.

Clinical Diagnosis and Management of Alzheimer's Disease, 2nd ed

P. Hedera, 2000 .

Treatment of Wilson Disease With Ammonium Tetrathiomolybdate: III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy

P. Hedera, F. Askari, J. Fink, 1996 .

Anatomical texture patterns identify cerebellar distinctions between essential tremor and Parkinson's disease

Kathleen E. Larson, B. Dawant, Ilwoo Lyu, 2021, Human brain mapping.

Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's disease.

Lauren Heusinkveld, Joseph S Neimat, Peter E Konrad, 2015, Parkinsonism & related disorders.

Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease.

R. Salomon, P. Konrad, C. Kao, 2014, Parkinsonism & related disorders.

Rotigotine adverse effects affecting patient's sexual partner.

P. Hedera, 2010, Clinical neuropharmacology.

Diagnosis and Treatment of Wilson's Disease With an Update on Anticopper Treatment for Other Diseases

P. Hedera, P. Moretti, F. Askari, 2004 .

Treatment of segmental continuous hypertrophic myokymia of the limb with botulinum A toxin

P. Hedera, Martin E. Brown, Muhammad Ismail Khalid Yousaf, 2022, SAGE open medical case reports.

Novel Type of Complicated Autosomal Dominant Hereditary Spastic Paraplegia Associated with Congenital Distal Arthrogryposis Type I

P. Hedera, P. Moretti, Jiali Zhao, 2018, Brain sciences.

A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia

A. Blitzer, R. Uitti, J. Perlmutter, 2014, Molecular genetics & genomic medicine.

The c.‐237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia

A. Blitzer, D. Tarsy, R. Uitti, 2011, Movement disorders : official journal of the Movement Disorder Society.

Pharmacotherapy of Essential Tremor

P. Hedera, T. Davis, F. Cibulčík, 2013, Journal of central nervous system disease.

Hereditary spastic paraplegia-causing mutations in atlastin-1 interfere with BMPRII trafficking

P. Hedera, Jiali Zhao, 2013, Molecular and Cellular Neuroscience.

A Novel Variant of ATP5MC3 Associated with Both Dystonia and Spastic Paraplegia

J. Winkelmann, P. Hedera, D. Gilbert, 2021, Movement Disorders.

Clinical and genetic features of cervical dystonia in a large multicenter cohort

J. Jankovic, J. Perlmutter, R. Rodriguez, 2016, Neurology: Genetics.

Spastic paraplegia, ataxia, mental retardation (SPAR): A novel genetic disorder

K. Lindblad, P. Hedera, M. Schalling, 2002, Neurology.

A novel genetic disorder

P. Hedera, 2002 .

Genetic variants in the IMPA2 gene do not confer increased risk of febrile seizures in Caucasian patients

P. Hedera, B. Abou-Khalil, M. Blair, 2007, European journal of neurology.

Identification of a Novel Locus for Febrile Seizures and Epilepsy on Chromosome 21q22

J. Haines, P. Hedera, Y. Bradford, 2006, Epilepsia.

Ethical Principles and Pitfalls of Genetic Testing for Dementia

P. Hedera, 2001, Journal of geriatric psychiatry and neurology.

Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations

R. Hennekam, L. Biesecker, J. Graham, 2010, Human mutation.

The GABBR1 locus and the G1465A variant is not associated with temporal lobe epilepsy preceded by febrile seizures

J. Sutcliffe, J. Haines, P. Hedera, 2005, BMC Medical Genetics.

Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3.

J. Beckmann, M. Hauser, K. Zerres, 2009, American journal of human genetics.

Maternal intrachromosomal insertional translocation leads to recurrent 1q21.3q23.3 deletion in two siblings

P. Hedera, T. Glover, J. Innis, 2012, American journal of medical genetics. Part A.

Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia

P. Hedera, J. Fink, T. Heiman-Patterson, 2001, Nature Genetics.

Oculo‐facio‐cardio‐dental syndrome: Skewed X chromosome inactivation in mother and daughter suggest X‐linked dominant Inheritance

P. Hedera, J. Gorski, 2003, American journal of medical genetics. Part A.

Novel locus for autosomal dominant hereditary spastic paraplegia, on chromosome 8q.

M. Leppert, P. Hedera, J. Fink, 1999, American journal of human genetics.

Novel polymerase gamma (POLG1) gene mutation in the linker domain associated with parkinsonism

P. Hedera, R. Dolhun, Erin M Presant, 2013, BMC Neurology.

Caenorhabditis elegans Models of Hereditary Spastic Paraplegia

P. Hedera, 2015 .

The second kindred with autosomal dominant distal myopathy linked to chromosome 14q: genetic and clinical analysis.

P. Hedera, E. Petty, J. Fink, 2003, Archives of neurology.

A Phase 2 Proof‐of‐Concept, Randomized, Placebo‐Controlled Trial of CX‐8998 in Essential Tremor

M. Versavel, R. Elble, K. Lyons, 2021, Movement disorders : official journal of the Movement Disorder Society.

Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson’s Disease

P. Konrad, P. Hedera, F. Phibbs, 2016, Journal of Parkinson's disease.

Deep brain stimulation in early Parkinson's disease: enrollment experience from a pilot trial.

R. Salomon, P. Konrad, Lily Wang, 2012, Parkinsonism & related disorders.

Front & Back Matter

Raúl San José Estépar, David S. Xu, J. M. Wong, 2013, Stereotactic and Functional Neurosurgery.

Differential Diagnosis of Movement Disorders in Clinical Practice

P. Hedera, A. Rana, 2013 .

White matter differences between essential tremor and Parkinson disease

Kalen J. Petersen, Meher R. Juttukonda, B. Dawant, 2018, Neurology.

Reappraisal of the role of the DRD3 gene in essential tremor.

P. Hedera, F. Phibbs, T. Davis, 2008, Parkinsonism & related disorders.

Familial essential tremor with apparent autosomal dominant inheritance: Should we also consider other inheritance modes?

J. Haines, P. Hedera, Y. Bradford, 2006, Movement disorders : official journal of the Movement Disorder Society.

A new locus for familial temporal lobe epilepsy on chromosome 3q

F. Andermann, M. Pandolfo, P. Hedera, 2013, Epilepsy Research.

Phenotypic analysis of autosomal dominant hereditary spastic paraplegia linked to chromosome 8q

S. Dimauro, P. Hedera, J. Fink, 1999, Neurology.

Clinical management of Wilson disease.

Peter Hedera, P. Hedera, 2019, Annals of translational medicine.

Differential degeneration of the cerebral microvasculature in Alzheimer's disease.

P. Hedera, R. Kalaria, 1995, Neuroreport.

Sex and electroencephalographic synchronization after photic stimulation predict signal changes in the visual cortex on functional MR images.

J. Lewin, P. Hedera, R. Friedland, 1998, AJNR. American journal of neuroradiology.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

R N Kalaria, D. Premkumar, P. Hedera, 1996, The American journal of pathology.

Botulinum Toxin Injection Techniques for the Management of Adult Spasticity

P. Hedera, H. Walker, Michael Y. Lee, 2015, PM & R : the journal of injury, function, and rehabilitation.

Pilot study assessing the feasibility of applying bilateral subthalamic nucleus deep brain stimulation in very early stage Parkinson's disease: study design and rationale.

R. Salomon, P. Konrad, C. Kao, 2012, Journal of Parkinson's disease.

WTX101 – an investigational drug for the treatment of Wilson disease

P. Hedera, A. Członkowska, P. Ferenci, 2018, Expert opinion on investigational drugs.

Metabolic Hyperactivity of the Medial Posterior Parietal Lobes in Psychogenic Tremor

P. Hedera, 2012, Tremor and other hyperkinetic movements.

Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial.

R. Salomon, P. Konrad, Lily Wang, 2015, Journal of Parkinson's disease.

Phenotypic Discordance in Siblings with Identical Compound Heterozygous PARK2 Mutations

P. Hedera, D. Claassen, David Isaacs, 2017, Brain sciences.

Catatonia With Thrombotic

J. Morris, Z. Khachaturian, E. Kokmen, 2004 .

The Allure of High-Risk Rewards in Huntington’s disease

Kristen E. Kanoff, P. Hedera, N. V. van Wouwe, 2015, Journal of the International Neuropsychological Society.

Novel autosomal dominant mandibulofacial dysostosis with ptosis: clinical description and exclusion of TCOF1

P. Hedera, E. Petty, H. Toriello, 2002, Journal of medical genetics.

Novel autosomal dominant mandibulofacial dysostosis with ptosis : clinical description and exclusion of TCOF 1 P Hedera

P. Hedera, E. Petty, H. Toriello, 2002 .

“Ears of the Lynx” MRI Sign Is Associated with SPG11 and SPG15 Hereditary Spastic Paraplegia

N. Bresolin, J. Masdeu, M. Riverol, 2019, American Journal of Neuroradiology.

Spastic Paraplegia 3A

P. Hedera, 2014 .

Infantile onset of hereditary spastic paraplegia poorly predicts the genotype.

P. Hedera, Wells Jn, M. Blair, 2007, Pediatric neurology.

Spinal cord magnetic resonance imaging in autosomal dominant hereditary spastic paraplegia

P. Hedera, P. Maly, J. Fink, 2005, Neuroradiology.

Recurrent de novo c.316G>A mutation in NIPA1 hotspot

P. Hedera, 2013, Journal of the Neurological Sciences.

Hereditary Spastic Paraplegia-Associated Mutations in the NIPA1 Gene and Its Caenorhabditis elegans Homolog Trigger Neural Degeneration In Vitro and In Vivo through a Gain-of-Function Mechanism

Emmanuel J. Botzolakis, R. Blakely, R. Macdonald, 2008, The Journal of Neuroscience.

Recurrent de novo c . 316 G N A mutation in NIPA 1 hotspot

P. Hedera, 2013 .

Effects of repeated abobotulinumtoxinA injections in upper limb spasticity

J. Gracies, P. Hedera, F. Boyer, 2017, Muscle & nerve.

Novel mental retardation–epilepsy syndrome linked to Xp21.1–p11.4

A. Beydoun, P. Hedera, J. Fink, 2002, Annals of neurology.

Concurrence of Alzheimer's disease, Parkinson's disease, diffuse Lewy body disease, and amyotrophic lateral sclerosis

R. Castellani, P. Hedera, R. Friedland, 1995, Journal of the Neurological Sciences.

Validating an objective video-based dyskinesia severity score in Parkinson's disease patients.

Benoit M. Dawant, R. E. Bodenheimer, Rui Li, 2013, Parkinsonism & related disorders.

Hereditary and metabolic myelopathies.

P. Hedera, 2016, Handbook of clinical neurology.

High-throughput mutational analysis of TOR1A in primary dystonia

A. Blitzer, D. Tarsy, R. Uitti, 2009, BMC Medical Genetics.

Confined Stimulation Using Dual Thalamic Deep Brain Stimulation Leads Rescues Refractory Essential Tremor: Report of Three Cases

P. Konrad, P. Hedera, Hong Yu, 2009, Stereotactic and Functional Neurosurgery.

FUS in familial essential tremor - the search for common causes is still on.

P. Hedera, M. LeDoux, F. Phibbs, 2013, Parkinsonism & related disorders.

Clinical Diagnosis and Management of Alzheimer's Disease

Peter Hedera, P. Hedera, 1997, Neurology.

Cortical Implications of Advancing Age and Disease Duration in Parkinson's Disease Patients with Postural Instability and Gait Dysfunction.

B. Dawant, D. Zald, B. Landman, 2016, Journal of Parkinson's disease.

Hereditary Myelopathies

P. Hedera, 2011, Continuum.

Tetrathiomolybdate versus Trientine in the Initial Treatment of Neurologic Wilson's Disease

P. Hedera, P. Moretti, F. Askari, 2008 .

Diagnosis and treatment of Wilson's disease.

P. Hedera, J. Fink, G. Brewer, 1999, Seminars in neurology.

Hepatolenticular Degeneration (wilson's Disease)

P. Hedera, J. Fink, G. Brewer, 1999 .

Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility.

P. Hedera, K. Harper, Maxim Turchan, 2020, Journal of gerontological nursing.

A Simple Bedside Screening Tool for Spasticity Referral

Claude J. Pirtle, P. Hedera, K. Harper, 2020, Clinical interventions in aging.

Clustering of dystonia in some pedigrees with autosomal dominant essential tremor suggests the existence of a distinct subtype of essential tremor

P. Hedera, F. Phibbs, T. Davis, 2010, BMC neurology.

Treatment of Wilson's disease motor complications with deep brain stimulation

P. Hedera, 2014, Annals of the New York Academy of Sciences.

Positive family history of essential tremor influences the motor phenotype of Parkinson's disease

P. Hedera, F. Phibbs, T. Davis, 2009, Movement disorders : official journal of the Movement Disorder Society.

Deep Brain Stimulation for Treatment of Tremor.

Wendell B. Lake, P. Konrad, P. Hedera, 2019, Neurosurgery clinics of North America.

Surgical targets for dystonic tremor: considerations between the globus pallidus and ventral intermediate thalamic nucleus.

P. Konrad, P. Hedera, F. Phibbs, 2013, Parkinsonism & related disorders.

“Because it is a rare disease…it needs to be brought to attention that there are things out of the norm”: a qualitative study of patient and physician experiences of Wilson disease diagnosis and management in the US

P. Hedera, N. Sahota, Uyen To, 2023, Orphanet Journal of Rare Diseases.

Treating post-traumatic tremor with deep brain stimulation: report of five cases.

P. Konrad, P. Hedera, F. Phibbs, 2013, Parkinsonism & related disorders.

Concomitants of visual hallucinations in Alzheimer's disease

R. Ownby, P. Whitehouse, P. Hedera, 1994, Neurology.

Delirium in Alzheimer Disease

P. Hedera, R. Friedland, E. Koss, 1997, Alzheimer disease and associated disorders.

Autosomal Dominant Lateral Temporal Epilepsy: Two Families with Novel Mutations in the LGI1 Gene

J. Sutcliffe, J. Haines, P. Hedera, 2004, Epilepsia.

Familial mesial temporal lobe epilepsy maps to chromosome 4q13.2-q21.3

J. Haines, F. Andermann, M. Pandolfo, 2007, Neurology.

Noninvasive Thalamotomy for Refractory Tremor by Frameless Radiosurgery.

C. Lindsell, A. Cmelak, P. Hedera, 2021, International journal of radiation oncology, biology, physics.

Short‐term Prognosis of Stroke Due to Occlusion of Internal Carotid Artery Based on Transcranial Doppler Ultrasonography

P. Hedera, P. Traubner, J. Bujdáková, 1992, Stroke.

Hereditary Spastic Paraplegia: Genetic Heterogeneity and Genotype-Phenotype Correlation

P. Hedera, J. Fink, John Fink1 , 2, 1999, Seminars in neurology.

Amyloid-beta protein angiopathies masquerading as Alzheimer's disease?

D. Premkumar, P. Hedera, R. Friedland, 1997, Annals of the New York Academy of Sciences.

White matter changes in Wilson disease.

P. Hedera, J. Fink, G. Brewer, 2002, Archives of Neurology.

Prenatal diagnosis of hereditary spastic paraplegia This article is a US Government work and is in the public domain in the USA.

P. Hedera, J. Fink, T. Tukel, 2001 .

Deep brain stimulation therapy of levodopa-responsive motor fluctuations in patients with multiple system atrophy

P. Hedera, D. Claassen, 2018 .

Prevalence of unilateral tremor in autosomal dominant essential tremor

P. Hedera, F. Phibbs, T. Davis, 2009, Movement disorders : official journal of the Movement Disorder Society.

The Application of Clinical Genetics Dovepress Update on the Clinical Management of Wilson's Disease

P. Hedera, 2022 .

Uva-dare (digital Academic Repository) Mutations in the Slow Skeletal Muscle Fiber Myosin Heavy Chain Gene (myh7) Cause Laing Early-onset Distal Myopathy (mpd1)

F. Mastaglia, P. Hedera, N. Laing, 2022 .

Dementia preceding motor symptoms in parkinson's disease: A case study

P. Hedera, R. Friedland, A. Lerner, 1994 .

The spastin jigsaw puzzle

P. Hedera, 2006, Neurology.

Encephalopathy associated with bismuth subgallate therapy.

P. Hedera, R. Friedland, E. Brass, 1993, Clinical neuropharmacology.

Neuroimaging of Vessel Amyloid in Alzheimer's Disease a, b

P. Hedera, R. Friedland, R. Kalaria, 1997, Annals of the New York Academy of Sciences.

Emerging strategies in the management of essential tremor

P. Hedera, 2017, Therapeutic advances in neurological disorders.

Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease

David G. Dobolyi, B. Dawant, D. Zald, 2016, Aging and disease.

Targeting for stereotactic radiosurgical thalamotomy based on tremor treatment response.

Brent D. Cameron, A. Cmelak, P. Hedera, 2021, Journal of neurosurgery.

Novel THAP1 sequence variants in primary dystonia

A. Blitzer, D. Tarsy, R. Uitti, 2010, Neurology.

Therapeutic Advances in Neurological Disorders

P. Hedera, 2017 .

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

A. Blitzer, D. Tarsy, R. Uitti, 2010, Human genetics.

Cryptococcal Meningitis Causing Refractory Hemichorea-Hemiballismus Treated With Pallidotomy

P. Konrad, P. Hedera, E. Wesley Ely, 2021, Cureus.

Abnormal connectivity of the visual pathways in human albinos demonstrated by susceptibility‐sensitized MRI

J. Lewin, E. Haacke, S. Lai, 1994, Neurology.

Novel Mutation in the SPG 3 A Gene in an African American Family With an Early Onset of Hereditary Spastic Paraplegia

G. Fenichel, P. Hedera, M. Blair, 2004 .

Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial

Simon E. Laganiere, Jamie L. Adams, L. Seeberger, 2023, The Lancet Neurology.

Hyperkinetic psychogenic movement disorders remain a diagnosis at first sight

P. Hedera, A. Gambardella, 2017, Neurology.